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Abstract - Biofilm represents a protected mode, which allows bacteria to survive and proliferate in a hostile environment. 
Little is known whether the ability to form biofilms is a characteristic of all groups of A streptococcal (GAS) strains and 
whether there is a relationship between biofilm formation and a clinical source of isolates. A capsule physically covers 
superficial adhesins and other proteins, essential in bacterial attachment, as the first step in biofilm formation. It is also 
possible that hyaluronic acid could form part of the complex extracellular polymer matrix of biofilms and contribute to the 
three-dimensional architecture of the biofilm. The aim of this study was to investigate if there are differences in adherence 
and biofilm production between GAS strains with different pathogenic potential, and the possible role of the capsule in this 
process. A total of 122 isolates were divided into three groups: noninvasive (NI), low invasive (LI) and highly invasive (HI). 
Adherence, SpeB and biofilm production were tested before and after hyaluronidase treatment. There was no difference 
in adherence between untreated GAS strains, but after capsule removal, NI and HI isolates adhered significantly better 
than the LI group. Before treatment, isolates of the HI group were the worst biofilm producers, but after capsule removal, 
they became the best biofilm producers. There was no difference in SpeB production among GAS isolates, regardless of the 
hyaluronidase treatment. 
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INTRODUCTION
Biofilm is a microbially derived sessile community 
characterized by cells that are irreversibly attached to 
a substratum and embedded in a matrix of extracel-
lular polymeric substances (Donlan and Costerton, 
2002). Biofilm represents a protected mode, which 
allows bacteria to survive and proliferate in a hostile 
environment. Its structure allows sufficient nutrients 
to sustain growth and, at the same time, protect the 
bacteria from toxic compounds and reagents present 
in the environment. (Costerton et al., 1999). 
Biofilms are of special significance in medicine. 
Many pathogenic and nosocomial bacteria with the 
ability to form biofilms are responsible for acute and 
chronic infections. It has been estimated by the Na-
tional Institute of Health (United States) that more 
than 80% of persistent bacterial infections are likely 
to involve biofilms (Bjarnsholt et al., 2002) Exam-
ples of typical biofilm-associated diseases are caries, 
gingivitis, periodontitis, endocarditis and prostatitis. 
Such infections are extremely difficult to eradicate 
because of the resistance of biofilm to numerous an-
timicrobial agents and products of the immune sys-1354 ALEKSANDRA ŠMITRAN ET AL.
tem (Donlan and Costerton, 2002; Costerton et al., 
1999).
Streptococcus pyogenes is a frequent cause of bac-
terial  diseases  worldwide.  Diseases  can  vary  from 
relatively mild tonsillopharyngitis and pyoderma to 
severe forms such as necrotizing fasciitis and septi-
cemia, which could be lethal (Cunningham, 2000). 
As far as biofilm is concerned, streptococcal species 
such  as  Streptococcus  gordonii  and  Streptococcus 
mutans are well-known biofilm formers (Ellen et al., 
1997; Jefferson, 2004), and recent observations sug-
gesting that biofilm may have a role in S. pyogenes 
infections have been reported. Hidalgo-Grass et al. 
(2004)  observed  that  structured  communities  ap-
pear to be present in necrotizing fasciitis lesions, and 
Neely et al. (2002) found similar characteristics in a 
model of S. pyogenes myositis in zebra fish. Recently, 
Ogava et al. (2011) proposed that biofilm formation 
or internalization into epithelial cells enable Strepto-
coccus pyogenes to establish pharyngeal carriage in 
patients with pharyngitis. However, little is known 
about whether the ability to form biofilms is a char-
acteristic of all group A streptococcal (GAS) strains 
and whether there is a relationship between biofilm 
formation and a clinical source of isolates.
Streptococcal  pyrogenic  exotoxin  B,  as  other 
streptococcal  pyrogenic  exotoxins,  was  first  well 
known for its pyrogenicity, enhancement of endo-
toxin  shock  and  superantigenic  effect  on  the  im-
mune system (Cunningham, 2000). Nowadays, SpeB 
is an extracellular cysteine protease capable of cleav-
ing both host and bacterial proteins and contributes 
to tissue damage and dissemination (Chiang-Ni and 
Wu, 2008). Doern et al. (2009) have found that SpeB 
degrades GAS extracellular proteins and host pro-
teins integral to the biofilm and contribute to bio-
film dispersal. Dispersal of the GAS biofilm and the 
constitutive production of SpeB would result in in-
creased virulence and tissue damage (Connolly et al, 
2011). SpeB production was found to be essential for 
establishing a murine skin infection that ultimately 
resulted in systemic infection, reduced clearance by 
the innate immune response and increased mortality 
(Lukomski et al., 1998). 
GAS capsule is made of hyaluronic acid, a high-
molecular-weight polymer (Girish and Kemparaju, 
2007). Besides its well known antiphagocytic role, 
the capsule attaches to CD44, a hyaluronic acid-
binding protein (Schrager et al., 1998) on human 
epithelial  cells,  which  induces  cytoskeletal  rear-
rangements and allows bacteria to stay extracellu-
lar as they penetrate the epithelium (Cywes et al., 
2001).  The  capsule  physically  covers  superficial 
adhesins and other proteins, essential in bacterial 
attachment, as the first step in biofilm formation 
(Schembri et al., 2004). It is also possible that hy-
aluronic acid will form part of the complex extra-
cellular polymer matrix of biofilms and contribute 
to  the  three-dimensional  architecture  of  biofilm 
(Pecharki et al., 2008).
The aim of this study was to investigate if there 
are  differences  in  adherence  and  biofilm  produc-
tion between GAS strains with different pathogenic 
potential and the possible role of the capsule in this 
process.
MATERIALS AND METHODS
Bacterial strains
A total of 172 Streptococcus pyogenes isolates used for 
biofilm testing were divided into three groups: (1) a 
noninvasive group (NI) obtained from carriers (100 
isolates); (2) a low invasive group (LI) isolated from 
patients with tonsillopharyngitis (50 isolates), and 
(3) a highly invasive (HI) group (22 isolates), isolated 
from the blood of patients with sepsis and necrotiz-
ing fasciitis obtained from the collection of the In-
stitute of Microbiology and Immunology, School of 
Medicine, Belgrade. 
Isolates were cultured on Columbia agar plates 
containing 5% sheep blood and stored at -80°C in 
Todd  Hewitt  broth  (Biolife,  Italy).  Identification 
was based on colony morphology, beta hemolysis, 
Gram-stain morphology, bacitracin sensitivity, tri-
methoprim-sulphometoxasole  resistance  and  slide 
agglutination test (Slidex Strepto-Kit, Bio-Merieux, 
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Growth conditions
Briefly, 1-2 colonies were picked from CBA, inocu-
lated in 2 ml Todd-Hewitt broth supplemented with 
1% yeast extract (THY) and incubated for 18-24 h 
at 37ºC in air. All isolates were tested for adherence, 
biofilm formation and SpeB production before and 
after hyaluronidase treatment, e.g. capsule removal. 
Hyaluronidase treatment
Bovine testicular hyaluronidase, type VI-S (Sigma-
Aldrich),  was  diluted  in  enzyme  diluent  (20  mM 
sodium phosphate, 77 mM sodium chloride, 0.01% 
bovine albumin, pH 7.0 at 37ºC) according to the 
manufacturer’s  instructions.  After  overnight  incu-
bation in THY, the broth culture was centrifuged at 
18000 rpm for 15 min, the pellet was washed with 
PBS (0.2 mM, pH 7), resuspended in PBS (0.2 mM, 
pH 6) and treated with bovine testicular hyaluroni-
dase, at a concentration of 5 U/ml broth culture for 
45 min at 37ºC, as previously described (Ofek et al., 
1983). The absence of a capsule was confirmed by In-
dia ink preparation.
Biofilm formation and adherence in uncoated 
polystyrene microtiter plates
Biofilm production was determined by the method 
described  by  Stepanović  et  al.  (2000)  with  minor 
Fig. 1. Proportion of adherent isolates of NI, LI and HI group before and after hyaluronidase treatment.1356 ALEKSANDRA ŠMITRAN ET AL.
modification in inoculum concentration. Briefly, 1-2 
colonies from CBA were inoculated in 2 ml Todd-
Hewitt  broth  supplemented  with  1%  yeast  extract 
(THY). After overnight incubation at 37ºC in air, 20 
μl of the broth culture were pipetted in 2 ml of fresh 
THY broth and from this prepared culture 100 μl 
were transferred to microtiter plates (Kartell, Italy) 
and incubated for 12, 24 and 48 h at 37ºC. The nega-
tive control contained broth only. The positive con-
trol was Staphylococcus epidermidis ATCC 14990. The 
plates were incubated at 37°C without shaking. Based 
on the OD produced by bacterial films and cut-off 
OD (ODc), strains were classified into the following 
categories: no biofilm producers, weak, moderate or 
strong biofilm producers. The cut-off OD (ODc) was 
defined as three standard deviations above the mean 
OD of the negative control. 
In order to test adherence to polystyrene, we in-
cubated microtiter plates with inoculum for 30 min 
at 37ºC in air. Strains with OD above the ODc were 
considered adherent to the microtiter plates.
SpeB production
SpeB production was tested according to the meth-
od described by Hynes and Tagg (1985). The GAS 
colony was stab inoculated into azocasein agar (Co-
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lumbia agar supplemented with 1.5% skimmed milk) 
and incubated overnight at 37ºC in air. Proteinase-
positive strains formed a translucent halo around the 
site of the stab. SpeB production was measured in 
millimeters as the radius of translucent zone around 
the GAS colony in azocasein agar.
Statistical analysis
Data analyses were done with SPSS version 20. ANO-
VA was applied to the results of adherence, SpeB and 
biofilm production between the three groups. Stu-
dent’s t-test was applied to the results when compar-
ing the data within the same group after and before 
the treatment. Both tests were considered significant 
if p<0.05, and very significant if p<0.01. 
RESULTS
As shown in Figure 1, there was no difference in ad-
herence to the polystyrene plate between untreated 
GAS strains (p=0.816). However, after capsule re-
moval, NI and HI isolates adhered significantly bet-
ter than the LI group (p ≤0.001). 
All tested S. pyogenes isolates were weak biofilm 
producers (OD values ODc <OD< 2xODc). There 
was no difference in biofilm production among all 
Fig. 3. Proportion of treated isolates that produce biofilm after 12, 24 and 48 h of incubation.1358 ALEKSANDRA ŠMITRAN ET AL.
the GAS strains after 12 h of incubation (p=0.262). 
After 24 h, the low invasive strains produced bio-
film significantly better than the other two groups 
(p=0.01), while after 48 h, LI and NI isolates pro-
duced considerably more biofilm than the HI group 
(p=0.014). However, after 24 and 48 h, the highly in-
vasive strains were the worst biofilm producers. 
After  hyaluronidase  treatment,  all  tested  GAS 
strains were still weak biofilm producers, but were 
better than before treatment. However, after 12 h of 
incubation, the highly invasive strains produced bio-
film significantly better than the other two groups of 
isolates (p=0.011). In the course of incubation (af-
ter 24 h), the low invasive strains increased biofilm 
production ( p≤0.001), while after 48 h, both HI and 
NI  isolates  produced  biofilm  in  a  similar  amount 
(p=0.011) (Figure 3.).
Regardless of the hyaluronidase treatment, there 
was a similar pattern of biofilm growth among all 
three groups of strains. For the NI, LI and HI groups, 
SpeB production before treatment was 11.7, 10.22 
and 11.09 millimeters, and 11.67, 10.56 and 11.36 
millimeters, respectively, after treatment There was 
no difference in SpeB production among GAS iso-
lates, regardless of the hyaluronidase treatment (p= 
0.253, p= 0.417 ). 
DISCUSSION
This work revealed that the adherence and biofilm 
production of both invasive and noninvasive GAS 
isolates increased after capsule removal. The capsule 
is a cell surface structure involved in virulence and 
colonization by virtue of its ability to create a hydrat-
ed protective layer around the bacteria and increase 
their resistance to phagocytosis and to the bacteri-
cidal effects of human serum. The virulence of S. py-
ogenes correlates closely with the expression of the 
hyaluronic acid capsule. Heavily capsulated strains 
spread more readily, while capsule production is re-
pressed during carriage. On the other hand, the at-
tachment of group A streptococci to pharyngeal or 
dermal epithelial cells is the most important initial 
step in the colonization of the host. Without strong 
adherence mechanisms, group A streptococci could 
not attach to host tissues and would be removed by 
mucous and salivary fluid flow mechanisms and ex-
foliation of the epithelium. Adhesins enable interac-
tions with host cells and extracellular matrix com-
ponents.  The  adhesion  process  involves  multiple 
group A streptococcal adhesins (lipoteichoic acid, M 
protein, fibrinogen, fibronectin and laminin binding 
protein, pili and many other proteins and carbohy-
drates) (Nobbs et al., 2009). The presence of multiple 
adhesins in the strains could give them the advantage 
of  more  avid  adherence  and  potentially  enhanced 
virulence. It could be assumed that the capsule hin-
ders the important adhesins or hydrophobic mole-
cules that mediate biofilm formation and absence of 
a capsule uncovers the components and allows better 
adherence and biofilm formation (Schembri et al., 
2004).
Although there are no data in literature that could 
explain the weaker adherence of the LI group, our 
presumption was that the isolates from patients with 
pharyngeal carriage (NI group) and invasive isolates 
(HI group) possess more adhesins or adhesins with 
higher affinity for cell receptors that allow isolates 
to strongly adhere to epithelial cells during carriage 
into deeper tissues in invasive infections. Our next 
goal will be to test the adherence of the same isolates 
to fibrinogen and laminin-coated microtiter plates to 
verify our conclusions.
Originally identified as a secreted product, SpeB 
was  found  to  be  associated  with  the  cell  surface, 
possibly via its pro-peptide moiety (Hytonen et al., 
2001). In this form, SpeB mediates adhesion to glyc-
oproteins and laminin, functions that may promote 
the colonization capabilities of GAS. When SpeB is 
associated with the cell surface, the capsule hinders 
SpeB, like other adhesins. SpeB is an extracellular 
cysteine protease that has been shown to cleave fi-
bronectin and vitronectin (Kapur et al., 1993a), ex-
tracellular matrix proteins and human interleukin-
1b into the active form of the molecule (Kapur et al, 
1993b). Therefore, the protease may be important in 
inflammation, shock and tissue destruction. Humans 
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cellulitis,  pneumonia,  bacteremia,  septic  arthritis, 
toxic shock syndrome and necrotizing fasciitis) all 
produced elevated levels of antibodies against strep-
tococcal  pyrogenic  exotoxin  B  following  infection 
(Gubba et al., 1998). Hence, we expected invasive 
isolates to produce more efficiently SpeB. However, 
we did not observe differences between the groups in 
SpeB production either before or after hyaluronidase 
treatment. We could this explain in two ways. Firstly, 
our method was not sensitive and precise enough to 
detect such fine differences between the isolates in 
SpeB production. Secondly, after capsule removal the 
isolates were grown for 24 h in azocasein agar con-
taining polysaccharides and, hence, they had enough 
time and substrate to synthesize a new capsule. Our 
goal in the future will be to measure SpeB produc-
tion by other methods that are more sensitive and 
exact. 
The  different  capabilities  of  biofilm  formation 
of S. pyogenes isolates were observed depending on 
their clinical origin. These differences were observed 
after 24 h and 48 h of incubation. It was noticed that 
initially, invasive non-treated isolates were the worst 
biofilm producers, while pharyngeal strains were the 
best. These results were expected, since we presumed 
that biofilm formation is not an essential virulence 
factor for highly invasive isolates. Baldassari et al. 
(2006) have found that the isolates that were able to 
invade cells with high efficiency were those produc-
ing the lowest amount of biofilm; the strong biofilm 
formers entered cells only with low efficiency. Simi-
lar results were found in experiments with S. pneu-
moniae (Moscoso et al., 2006, Garcia et al., 2007), al-
though the role of pneumococcal adhesins in patho-
genesis and their contribution to biofilm production 
have not been investigated as well as GAS adhesins. 
However,  we  expected  that  among  all  strains  the 
noninvasive isolates would be the most potent bio-
film producers, because it was assumed that pharyn-
geal carriage might be due to biofilm formation (Bal-
dassari et al., 2006). Another possible explanation 
for streptococcal carriage is internalization into epi-
thelial cells (Marouni and Sela, 2004), although GAS 
were  considered  to  be  extracellular  bacteria.  Our 
results support intracellular internalization as a pos-
sible mechanism of carriage in the throat. There was 
no difference in biofilm stability among the strains. 
These results were expected, because there is no cor-
relation in literature between GAS and diseases asso-
ciated with biofilm and indwelling medical devices. 
After hyaluronidase treatment, biofilms produc-
tion was improved in all isolates. Surprisingly, the 
highly invasive isolates were the best biofilm produc-
ers of all the strains. The pattern of biofilm growth in 
all the GAS isolates was comparable before and after 
capsule removal. 
It is important to note that although the capsule 
was  removed  during  hyaluronidase  treatment,  the 
strains  synthesized  a  new  capsule  during  incuba-
tion in the broth. It is well known that a capsule is 
essential  for  the  three-dimensional  architecture  of 
biofilm (Danese et al., 2000). We believe that at the 
beginning  of  incubation  capsule  removal  enabled 
the good adherence of the highly invasive isolates. 
However, during the incubation, these isolates pro-
duced thicker capsules, which probably contributed 
to  subsequent  better  biofilm  formation  among  all 
the isolates. In an experiment with S. intermedius, 
Pecharki et al. (2008) obtained similar results. Nev-
ertheless, Sugareva et al. (2010) did not find a cor-
relation between capsule and biofilm formation. Cho 
and Caparon (2005) found that the GAS hyaluronic 
acid capsule was not required for biofilm formation 
in a static system, but that following initial attach-
ment, no bacterial aggregation or biofilm production 
under flow conditions occurred in mutants lacking 
the capsule. In addition, none of the authors could 
not estimate if serotype specificity affected biofilm 
formation. Another important question is why the 
GAS capacity to form biofilm appears not to be uni-
versal but rather strain-dependent.
To the best of our knowledge, this is the first 
work in which biofilm production was examined af-
ter enzymatic removal of the GAS capsule. We do not 
exactly know the mechanism whereby the removal 
of the capsule affects biofilm formation, and plan to 
investigate this in the future. At present we still don’t 
know enough about biofilm formation in S. pyogenes. 1360 ALEKSANDRA ŠMITRAN ET AL.
Further study of GAS biofilm formation will provide 
new insights into the pathogenesis of GAS.
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